ALG-055009, Publications A multipart phase 1 study of the safety, pharmacodynamics and pharmacokinetics of ALG-055009, a novel thyroid hormone receptor beta (THR-β) agonist for metabolic dysfunction-associated steatohepatitis (MASH), in healthy participants
Pevifoscorvir-sodium, Publications The CAM-E ALG-001075 potently reduces HBV cccDNA in preclinical experiments
Preclinical, Publications Antisense oligonucleotide-based strategy to target hepatitis delta virus infections
Preclinical, Publications Differential impact of CAM-E and CAM-A on hepatitis B core protein phosphorylation states in vitro
Preclinical, Publications PML nuclear bodies store aggregated HBc and reduce CAM-induced apoptosis in HBc-expressing cells
Preclinical, Publications Antisense oligonucleotides as drugs with both direct and indirect antiviral actions
ALG-097558, Publications Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro Inhibitor
Pevifoscorvir-sodium, Publications European Association for the Study of the Liver Congress (EASL) 2025 Satellite Symposium Recording